Diabetes Risk After Cancer Treatment: Why Glucose Drifts and What to Do Early
Steroids, androgen deprivation, transplant medication, abdominal radiation, and reduced activity all push glucose upward in survivorship, where it compounds cardiac risk. How to catch it before it settles.
Blood sugar frequently drifts upward after cancer treatment, and because the drift is gradual it tends to be found late. In survivorship it matters particularly, because glucose and cardiac risk compound each other.
Why glucose rises
Repeated corticosteroid courses raise glucose directly. Androgen deprivation and induced menopause increase insulin resistance. Calcineurin inhibitors after transplant affect insulin secretion. Radiation involving the pancreas or abdomen can reduce insulin output years later. Reduced activity and weight change during treatment sit on top of all of it.
Checkpoint inhibitors can additionally cause sudden insulin-dependent diabetes, which behaves differently and can present acutely.
Testing, and a caveat
HbA1c is the usual test, but it reflects red cell lifespan, so recent anaemia, transfusion, or marrow recovery can distort it. Where that applies, a fasting glucose or a glucose tolerance test gives a cleaner answer, and it is reasonable to ask which is appropriate for your situation.
A post-treatment baseline followed by testing on an agreed interval is more useful than opportunistic checks years apart.
Why it compounds cardiac risk
Raised glucose accelerates vascular disease, worsens lipids, and drives blood pressure upward. In a survivor with prior anthracycline exposure or chest radiation, this stacks on a heart with less reserve. Treating glucose early is therefore also cardiac protection, not a separate project.
What to do at the prediabetes stage
This is the point of maximum return. Rebuilding activity, particularly resistance work, adjusting diet toward whole foods and lower refined carbohydrate, and addressing sleep and weight all move glucose measurably. Medication is added where thresholds are met, with dosing checked against kidney function, which is often reduced after treatment.
Frequently asked questions
- Can cancer treatment cause diabetes?
- It can. Steroid courses, androgen deprivation, transplant medications, and radiation involving the pancreas all raise glucose, and checkpoint inhibitors can cause sudden insulin-dependent diabetes.
- Is HbA1c reliable after chemotherapy?
- Not always. Because it depends on red cell lifespan, recent anaemia, transfusion, or marrow recovery can distort it, and a fasting glucose or tolerance test may be more accurate.